Page 70 - NobleCon21

Health Care
Date November 20, 2025 Health Care
52wk High $35.56
52wk Low $17.73 Electromed, Inc. ELMD $25.65
500 Sixth Avenue NW
New Prague, MN 56071

(USD - in millions) smartvest.com
Market Cap 210.3
Enterprise 196.3
Basic Shares Out. 8.34 COMPANY OVERVIEW
Float 6.58
Institutional Holdings 51.42% Detailed Analysis:Channelchek.com
Short Interest 0.25
Avg. 90-Day Volume 0.07 Electromed (NYSE American: ELMD) is a profitable and growing
medical device company that develops, manufactures, markets and
sells innovative High Frequency Chest Wall Oscillation (HFCWO)
airway clearance products, primarily for use in the home setting. Our
EPS Data flagship product, the SmartVest® Airway Clearance System, is a
differentiated device designed for patient comfort and ease of use. We
2022 2023 2024 believe the domestic market for HFCWO devices is largely untapped,
CQ1 0.07 0.12 0.17 with fewer than 15% of the approximately 824,000 patients diagnosed
CQ2 0.04 0.12 0.20 with bronchiectasis in the US currently using this non-invasive therapy.

CQ3 0.01 0.02 0.16
CQ4 0.11 0.19 0.22
CY 0.23 0.45 0.75 Source: Channelchek/QuoteMedia

Long-Term EPS Estimate 15.40
Price/Book (mrq) 5.35
ROE (ttm) 19.02
Debt-to-Total Cap. (mrq) 0.25
Fiscal Year End 30-Jun

500 Sixth AvenNew Prague MN 56071

Key Executives
CEO: Cunniff, James
CFO: Nagel, Bradley
COO: N/A
IR: N/A
Noble Capital Markets, Inc.
Source: Capital IQ, Noble Financial estimates, company filings
Noble Senior Analyst 561-994-1191 noblecapitalmarkets.com
Robert LeBoyer MEMBERS: FINRA, SIPC, MSRB
rleboyer@noblelsp.com Following the conference, complete video library of presentations will be
available at: channelchek.com | nobleconference.com
(212) 896-4625

Refer to the back of the book for disclosures